EFIL – RETURN TO LIFE DRUG ELUTING STENT
EFIL – return to life® reunites the performance of Sirolimus drug with long-term advantages of a safe biodegradable polymer based drug delivery matrix released from a thin strut Co-Cr stent system.
SPECIFICATIONS

- Hybrid and flexible stent design.
- Thin strut cobalt chromium stent with surface modification for better drug delivery.
- Uniform drug coating on abluminal surface using patented stent coating technology for drug release only to targeted tissue.
- Highly safe biodegradable polymer matrix.
- Protective top coat ensures better polymer-drug binding with negligible polymer flaking during stent expansion.
- Biodegradable polymer matrix completely degrades in 6 – 9 months leaving behind bare metal stent.
SIZES
